ÂÜÀòÂÒÂ×

Kelly Vandever currently serves as the Director of Clinical Operations at Celcuity since August 2024. Prior experience includes multiple leadership roles at MEI Pharma from July 2019 to July 2024, and previous positions at Spruce Biosciences, Regulus Therapeutics, Auspex Pharmaceuticals, and PRA Health Sciences. Kelly possesses extensive expertise in overseeing clinical trial operations, ensuring compliance with regulatory standards, managing project budgets and timelines, and facilitating communication among stakeholders. Kelly's background includes significant contributions to site management, clinical project documentation, and the training of team members, demonstrating a robust capacity for maintaining high-quality operational standards across various clinical development phases.